Fernando M Tome

Title: Innovations of Fernando M Tome in Muscular Dystrophy Research

Introduction

Fernando M Tome is a notable inventor based in Paris, France. He has made significant contributions to the field of muscular dystrophy research, particularly through his innovative patents. With a total of 2 patents, his work focuses on advancing the diagnosis and understanding of congenital muscular dystrophies.

Latest Patents

One of Tome's latest patents addresses merosin deficiency-type congenital muscular dystrophy. This patent discloses a method for aiding in the diagnosis of this condition, based on the discovery of a previously unidentified form characterized by a substantial reduction in merosin levels in skeletal muscle tissue. Another significant patent involves the identification of a nucleic acid sequence encoding a mammalian 43 kDa non-dystrophin component, known as β-sarcoglycan. This patent also discusses immunogenic peptides that stimulate the production of antibodies specific to β-sarcoglycan, as well as mutations associated with autosomal recessive limb-girdle muscular dystrophy.

Career Highlights

Fernando M Tome is affiliated with the University of Iowa Research Foundation, where he continues to contribute to groundbreaking research in his field. His work has implications for the diagnosis and treatment of muscular dystrophies, showcasing his commitment to advancing medical science.

Collaborations

Tome has collaborated with esteemed colleagues such as Kevin P Campbell and Yoshihide Sunada. These partnerships have further enriched his research and innovation efforts.

Conclusion

Fernando M Tome's contributions to muscular dystrophy research through his patents highlight his role as a leading inventor in the field. His innovative methods and discoveries are paving the way for improved diagnosis and understanding of these complex conditions.